Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wyeth receives approvable letter for osteoporosis drug
In the letter, the FDA requested information similar to that outlined in its approvable letter for bazedoxifene’s new drug application for the prevention of postmenopausal osteoporosis issued in
In the letter, the FDA requested information similar to that outlined in its approvable letter for bazedoxifene’s new drug application for the prevention of postmenopausal osteoporosis issued in
Rifampin for Injection is a semi synthetic antibiotic indicated for the treatment of both tuberculosis and meningococcal carriers. Akorn-Strides is a joint venture that was formed in 2005
The randomized, double-blind, placebo controlled, parallel group study established clinical proof-of-concept and demonstrated a statistically significant improvement over placebo in the endpoint of overall subject global assessment of
The Covidien Single-Incision Laparoscopic Surgery (SILS) Procedure Kit is scheduled for commercialization in the summer of 2008, and customized kit solutions are also forthcoming to enable SILS procedures
Dr Andreas Pfuetzner, Biodel’s current chief medical officer (CMO) will remain on Biodel’s management team as the company’s CMO in Europe and as a member of the company’s
The BacJac system is designed to relieve pain in patients with neurogenic intermittent claudication due to lumbar spinal stenosis. The BacJac achieves spinal decompression by limiting the symptomatic
The Stature VBR is a radiolucent MIS compatible spacer system designed to utilize a self-distracting technique in the treatment of various pathologies of the thoracic and lumbar spine.
His responsibilities include overseeing and managing all aspects of the PEGylation Business Unit, including research and manufacturing, as well as operations across the company. He will also serve
Omez Insta is an advanced formulation of omeprazole, internationally referred to as IR –Ome (Immediate Release Omeprazole). IR-Ome is said to be the first and only immediate release
The settlement requires Kyphon to pay $75 million plus accrued interest to the US, to settle allegations relating to reimbursement advice that the company gave to customers regarding